adriamycinol has been researched along with Stomatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adkins, D; Butrynski, JE; Chawla, SP; Cranmer, LD; Ganjoo, KN; Kroll, S; Langmuir, VK; Lorente, G; Okuno, SH; Rushing, D | 1 |
| Ackland, SP; Choi, KE; Ratain, MJ; Ruane, M; Sinkule, JA; Vogelzang, NJ | 1 |
1 trial(s) available for adriamycinol and Stomatitis
| Article | Year |
|---|---|
A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.
Topics: Abscess; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cellulitis; Disease-Free Survival; Doxorubicin; Drug Eruptions; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphopenia; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neutropenia; Nitroimidazoles; Phosphoramide Mustards; Sarcoma; Stomatitis; Treatment Outcome; Young Adult | 2011 |
1 other study(ies) available for adriamycinol and Stomatitis
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin.
Topics: Adult; Aged; Blood Cell Count; Doxorubicin; Female; Humans; Infusion Pumps; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Risk Factors; Stomatitis | 1989 |